Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1990 3
1991 2
1992 2
1993 1
1994 3
1995 2
1996 4
1997 7
1998 2
1999 1
2000 2
2001 5
2002 5
2003 4
2004 4
2005 6
2006 4
2007 8
2008 5
2009 5
2010 9
2011 4
2012 10
2013 12
2014 5
2015 8
2016 6
2017 5
2018 2
2019 4
2020 6
2021 1
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
The role of [(18)F]fluorodopa positron emission tomography in grading of gliomas.
Roach JR, Plaha P, McGowan DR, Higgins GS. Roach JR, et al. J Neurooncol. 2022 Dec;160(3):577-589. doi: 10.1007/s11060-022-04177-3. Epub 2022 Nov 24. J Neurooncol. 2022. PMID: 36434486 Free PMC article. Review.
Positron emission tomography (PET) imaging with amino acid tracers such as [(18)F]fluorodopa ((18)F-FDOPA), [(11)C]methionine ((11)C-MET), [(18)F]fluoroethyltyrosine ((18)F-FET), and (18)F-FDOPA are being increasingly used in the diagnosis and management of gliomas. ...
Positron emission tomography (PET) imaging with amino acid tracers such as [(18)F]fluorodopa ((18)F-FDOPA), [(11)C]methionine ((11)C- …
Relevance of Fluorodopa PET Scan in Dopamine Responsive Dystonia and Juvenile Parkinsonism: A Systematic Review.
Moncayo JA, Vargas M, Ortiz JF, Granda P, Aguirre AS, Argudo J, Tambo W, Garofalo G, Capirig CJ, German-Montenegro M, Rueda LG. Moncayo JA, et al. Neurol Int. 2022 Dec 2;14(4):997-1006. doi: 10.3390/neurolint14040079. Neurol Int. 2022. PMID: 36548184 Free PMC article. Review.
We only used human clinical trials about dopamine responsive dystonia and juvenile parkinsonism patients in which a fluorodopa (FD) positron emission tomography (PET) scan was performed to identify its use in these diseases. ...
We only used human clinical trials about dopamine responsive dystonia and juvenile parkinsonism patients in which a fluorodopa (FD) p …
Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.
Ito T, Jensen RT. Ito T, et al. Curr Opin Endocrinol Diabetes Obes. 2017 Feb;24(1):15-24. doi: 10.1097/MED.0000000000000300. Curr Opin Endocrinol Diabetes Obes. 2017. PMID: 27875420 Free PMC article. Review.
Particularly important is the rapid replacement in somatostatin receptor scintigraphy of In-diethylenetriamine penta-acetic acid-single-photon emission computed tomography/computed tomography (CT) by Ga-fluorodopa(F-D)PA), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraaceti …
Particularly important is the rapid replacement in somatostatin receptor scintigraphy of In-diethylenetriamine penta-acetic acid-single-phot …
Approaches to PET Imaging of Glioblastoma.
Drake LR, Hillmer AT, Cai Z. Drake LR, et al. Molecules. 2020 Jan 28;25(3):568. doi: 10.3390/molecules25030568. Molecules. 2020. PMID: 32012954 Free PMC article. Review.
Previously used PET imaging agents include the tracers for markers of proliferation ([(11)C]methionine; [(18)F]fluoro-ethyl-L-tyrosine, [(18)F]Fluorodopa,[(18)F]fluoro-thymidine, and [(18)F]clofarabine), hypoxia sensing ([(18)F]FMISO, [(18)F]FET-NIM, [(18)F]EF5, [(18)F]HX4 …
Previously used PET imaging agents include the tracers for markers of proliferation ([(11)C]methionine; [(18)F]fluoro-ethyl-L-tyrosine, [(18 …
Novel PET tracers: added value for endocrine disorders.
Bergeret S, Charbit J, Ansquer C, Bera G, Chanson P, Lussey-Lepoutre C. Bergeret S, et al. Endocrine. 2019 Apr;64(1):14-30. doi: 10.1007/s12020-019-01895-z. Epub 2019 Mar 14. Endocrine. 2019. PMID: 30875057 Review.
Role of imaging test with radionuclides in the diagnosis and treatment of pheochromocytomas and paragangliomas.
Araujo-Castro M, Pascual-Corrales E, Alonso-Gordoa T, Molina-Cerrillo J, Martínez Lorca A. Araujo-Castro M, et al. Endocrinol Diabetes Nutr (Engl Ed). 2022 Oct;69(8):614-628. doi: 10.1016/j.endien.2022.11.011. Epub 2022 Nov 16. Endocrinol Diabetes Nutr (Engl Ed). 2022. PMID: 36402734 Review.
Radionuclide imaging tests with [(123)I] Metaiodobenzylguanidine (MIBG), [(18)F] -fluorodeoxyglucose, [(18)F]-fluorodopa, or (68)Ga-DOTA(0)-Tyr(3)-octreotate are useful for the diagnosis, staging and follow-up of pheochromocytomas (PHEOs) and paragangliomas (PGLs) (PPGLs). …
Radionuclide imaging tests with [(123)I] Metaiodobenzylguanidine (MIBG), [(18)F] -fluorodeoxyglucose, [(18)F]-fluorodopa, or (68)Ga-D …
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Cuccurullo V, Di Stasio GD, Mansi L. Cuccurullo V, et al. Curr Radiopharm. 2019;12(2):98-106. doi: 10.2174/1874471012666190206094555. Curr Radiopharm. 2019. PMID: 30727940 Review.
The theranostic model based on SSTR does not work in insulinoma, in which different radiotracers such as F-18 FluoroDOPA or tracers for the glucagon-like peptide-1 receptor have to be preferred....
The theranostic model based on SSTR does not work in insulinoma, in which different radiotracers such as F-18 FluoroDOPA or tracers f …
34 results